CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01576276
NCT01576276N/ACompleted

A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects

Massachusetts General Hospital·interventional·Posted Apr 12, 2012·Updated Jun 29, 2018

In Brief

A clinical study evaluating Integrated MR-PET scan and Ketorolac for Healthy Controls. Completed, enrolled 51 participants across 1 site.

Detailed Summary

Healthy right-handed volunteers aged 21 to 50 needed for a research study of the effects of morphine and ketorolac on brain activity in response to pain stimuli as measured by functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET). Study will be conducted on six separate days not requiring an overnight stay in the hospital.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 12, 2012
Enrollment StartApr 1, 2012
Primary CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 14.2 years ago

Interventions

Integrated MR-PET scanradiation

Integrated MR-PET scan using \[11C\]diprenorphine

Ketorolacdrug

3 administrations of ketorolac over course of study